Chaperonin 10 variants

The invention relates generally to chaperonin 10 N-terminal variants. More specifically, the invention relates to chaperonin 10 N-terminal variants with enhanced immunomodulatory capacity and/or enhanced binding affinity for pathogen-associated molecular patterns (PAMPs) and/or damage-associated mol...

Full description

Saved in:
Bibliographic Details
Main Authors NAYLOR DEAN JASON, BROWN RICHARD JAMES, HOWARD CHRISTOPHER BRUCE, WARD LINDA ALLISON, VAN HEUMEN WALTER RENE ANTONIUS, STOK JEANETTE ELIZABETH, LAMBERT DANIEL SCOTT, DE BAKKER CHRISTOPHER JOHN, JAMES ANDREW LEIGH, RALSTON KYLIE JANE
Format Patent
LanguageEnglish
Published 13.01.2015
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
Online AccessGet full text

Cover

More Information
Summary:The invention relates generally to chaperonin 10 N-terminal variants. More specifically, the invention relates to chaperonin 10 N-terminal variants with enhanced immunomodulatory capacity and/or enhanced binding affinity for pathogen-associated molecular patterns (PAMPs) and/or damage-associated molecular patterns (DAMPs).
Bibliography:Application Number: US201013500159